Tower Research Capital LLC (TRC) - SENSEI BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,807
-31.8%
7,259
-2.8%
0.00%
Q2 2023$8,516
+283766.7%
7,470
+282.1%
0.00%
Q1 2023$30.0%1,955
-7.3%
0.00%
Q4 2022$3
-100.0%
2,110
-56.4%
0.00%
Q3 2022$7,000
-30.0%
4,837
+10.4%
0.00%
Q2 2022$10,000
-9.1%
4,382
-7.8%
0.00%
Q1 2022$11,000
-47.6%
4,751
+31.1%
0.00%
Q4 2021$21,000
+162.5%
3,623
+367.5%
0.00%
Q3 2021$8,000
-42.9%
775
-45.0%
0.00%
Q2 2021$14,000
+75.0%
1,410
+147.4%
0.00%
Q1 2021$8,0005700.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders